Based on her EBV serology (positive VCA IgG, negative VCA IgM, markedly elevated NA‑1 IgG, and positive EA‑D IgG), does she have an active Epstein‑Barr virus infection or only evidence of prior exposure?

EBV Serology Interpretation: Past Infection, Not Active Disease

This serological pattern (positive VCA IgG, negative VCA IgM, markedly elevated EBNA-1 IgG >600 U/mL, and positive EA-D IgG) indicates past EBV infection rather than acute or currently active infection. The absence of VCA IgM is the critical distinguishing feature that rules out acute primary infection 1, 2.

Serological Pattern Analysis

Classic Past Infection Profile

• The presence of VCA IgG with EBNA-1 IgG in the absence of VCA IgM is the hallmark serological pattern of past EBV infection 1, 2
• The markedly elevated EBNA-1 IgG (>600 U/mL, reference <18 U/mL) strongly supports remote infection, as EBNA-1 antibodies typically appear 10-12 days after symptom onset and persist for years 3
• VCA IgM antibodies are detectable 3-5 days after symptom onset in primary infection and remain for 2-3 months; their absence here excludes acute infection 3

The EA-D IgG Positivity

• The positive EA-D IgG does not indicate active infection in this context 2
• EA-D antibodies can persist for months to years after primary infection in some individuals 2
• EA-D positivity alone, without VCA IgM, does not meet criteria for active disease 2

Excluding Chronic Active EBV (CAEBV)

Why This Is Not CAEBV

CAEBV requires three mandatory criteria, which this patient does not meet based on serology alone 3:

1. Persistent or recurrent infectious mononucleosis-like symptoms (fever, lymphadenopathy, hepatosplenomegaly) - clinical information not provided 3
2. Unusual antibody pattern with raised anti-VCA AND anti-EA - while both are positive, CAEBV typically shows VCA-IgG titers ≥1:640 and EA-IgG ≥1:160, plus often positive IgA antibodies to VCA/EA 3
3. Detection of increased EBV genomes in peripheral blood - CAEBV requires ≥10,000 IU/mL EBV DNA in whole blood 4

Critical Distinction

• The 2023 updated CAEBV guidelines now require confirmation of high EBV DNA load (≥10,000 IU/mL) and demonstration of EBV-infected T or NK cells 4
• Serology alone cannot diagnose CAEBV; molecular testing is mandatory 4
• This patient's serological pattern is inconsistent with CAEBV, which typically shows extraordinarily elevated titers and persistent symptoms 3

Common Pitfalls to Avoid

The Triple-Positive Pattern Confusion

• When all three markers (VCA IgG, VCA IgM, EBNA-1 IgG) are positive simultaneously, this can represent either late primary infection or serological reactivation 5
• However, this patient is NOT triple-positive because VCA IgM is negative 5
• Studies show that 49% of patients with suspected primary EBV infection who have all three markers positive actually have reactivation with false-positive IgM 5

False-Positive VCA IgM Considerations

• VCA IgM detected alone or with atypical patterns can be false-positive in 52.8% of cases, sometimes due to CMV cross-reactivity 6
• The absence of VCA IgM in this case strengthens the interpretation of past infection 6

Cross-Reactivity Warning

• The laboratory note about EA-D IgG cross-reactivity with HIV antibodies is important - HIV infection should be excluded if clinical suspicion exists, though this does not change the EBV interpretation [@laboratory report@]
• This cross-reactivity affects EA-D testing specifically and does not invalidate the overall interpretation of past EBV infection [@laboratory report@]

Clinical Implications

If Symptoms Are Present

• If this patient has current mononucleosis-like symptoms, alternative diagnoses should be pursued (CMV, toxoplasmosis, acute HIV, other viral infections) 2
• The serological pattern definitively excludes acute primary EBV as the cause of current symptoms 1, 2
• Consider EBV PCR quantification only if CAEBV is clinically suspected based on persistent severe symptoms, but serology makes this unlikely 4

No Further EBV Testing Needed

• No additional EBV serological testing is indicated unless there is strong clinical suspicion for CAEBV with appropriate symptoms 3, 4
• IgG avidity testing would be unnecessary here as the negative VCA IgM already excludes recent infection 5